Literature DB >> 11189450

Heat shock proteins: the fountainhead of innate and adaptive immune responses.

S Basu1, P K Srivastava.   

Abstract

The ability of heat shock proteins to (1) chaperone peptides, including antigenic peptides; (2) interact with antigen-presenting cells through a receptor; (3) stimulate antigen-presenting cells to secrete inflammatory cytokines; and (4) mediate maturation of dendritic cells, makes them a unique starting point for generation of immune responses. These properties also permit the use of heat shock proteins for development of a new generation of prophylactic and therapeutic vaccines against cancers and infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11189450      PMCID: PMC312875          DOI: 10.1379/1466-1268(2000)005<0443:hsptfo>2.0.co;2

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  63 in total

1.  Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway.

Authors:  S Basu; R J Binder; R Suto; K M Anderson; P K Srivastava
Journal:  Int Immunol       Date:  2000-11       Impact factor: 4.823

Review 2.  Immunotherapy of human cancer: lessons from mice.

Authors:  P K Srivastava
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

3.  Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells.

Authors:  R J Binder; M L Harris; A Ménoret; P K Srivastava
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

4.  CD91: a receptor for heat shock protein gp96.

Authors:  R J Binder; D K Han; P K Srivastava
Journal:  Nat Immunol       Date:  2000-08       Impact factor: 25.606

5.  Identification of the peptide-binding site in the heat shock chaperone/tumor rejection antigen gp96 (Grp94).

Authors:  N A Linderoth; A Popowicz; S Sastry
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

6.  HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine.

Authors:  A Asea; S K Kraeft; E A Kurt-Jones; M A Stevenson; L B Chen; R W Finberg; G C Koo; S K Calderwood
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

7.  Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway.

Authors:  K Suzue; X Zhou; H N Eisen; R A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

8.  Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study.

Authors:  S Janetzki; D Palla; V Rosenhauer; H Lochs; J J Lewis; P K Srivastava
Journal:  Int J Cancer       Date:  2000-10-15       Impact factor: 7.396

9.  Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways.

Authors:  F Castellino; P E Boucher; K Eichelberg; M Mayhew; J E Rothman; A N Houghton; R N Germain
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

10.  Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.

Authors:  H Singh-Jasuja; R E Toes; P Spee; C Münz; N Hilf; S P Schoenberger; P Ricciardi-Castagnoli; J Neefjes; H G Rammensee; D Arnold-Schild; H Schild
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  27 in total

1.  Serum and lymphocyte levels of heat shock protein 70 in aging: a study in the normal Chinese population.

Authors:  Xingfang Jin; Ruibo Wang; Chengfeng Xiao; Longxian Cheng; Feng Wang; Li Yang; Taoyi Feng; Ming Chen; Sheng Chen; Xiaoye Fu; Jie Deng; Ru Wang; Fangfang Tang; Qingyi Wei; Robert M Tanguay; Tangchun Wu
Journal:  Cell Stress Chaperones       Date:  2004-03       Impact factor: 3.667

Review 2.  Antibodies against heat shock proteins in environmental stresses and diseases: friend or foe?

Authors:  Tangchun Wu; Robert M Tanguay
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

Review 3.  Mechanisms of HSP72 release.

Authors:  Alexzander Asea
Journal:  J Biosci       Date:  2007-04       Impact factor: 1.826

4.  Initiation of the Immune Response by Extracellular Hsp72: Chaperokine Activity of Hsp72.

Authors:  Alexzander Asea
Journal:  Curr Immunol Rev       Date:  2006-08

Review 5.  Secreted heat shock protein-90 (Hsp90) in wound healing and cancer.

Authors:  Wei Li; Divya Sahu; Fred Tsen
Journal:  Biochim Biophys Acta       Date:  2011-09-25

Review 6.  The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules.

Authors:  Freidrich M Cruz; Jeff D Colbert; Elena Merino; Barry A Kriegsman; Kenneth L Rock
Journal:  Annu Rev Immunol       Date:  2017-01-11       Impact factor: 28.527

7.  Heat shock protein 90 expression in Epstein-Barr virus-infected B cells promotes gammadelta T-cell proliferation in vitro.

Authors:  Maria Kotsiopriftis; Jerome E Tanner; Caroline Alfieri
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

8.  Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R.

Authors:  Sergey Iordanskiy; Yuqi Zhao; Larisa Dubrovsky; Tatiana Iordanskaya; Mongzhong Chen; Dong Liang; Michael Bukrinsky
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Gastric transcription profile of Helicobacter pylori infection in the rhesus macaque.

Authors:  Jennifer L Huff; Lori M Hansen; Jay V Solnick
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Purification of heat shock protein 70-associated tumor peptides and their antitumor immunity to hepatoma in mice.

Authors:  Dai-Xiong Chen; Yan-Rong Su; Gen-Ze Shao; Zhen-Chao Qian
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.